Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

90 recalls, newest first

Risk Class IClass IIClass III
Status OngoingCompletedTerminated
Year 20262025202420232022 2013 All years
Cause Sterility / contaminationNitrosamine impurityChemical / undeclaredParticulate / foreign matterLabeling / mix-upcGMP deviationMicrobial contamination All causes
Class II · Moderate risk

Carisoprodol Tablets

Presence of Foreign Substance; metal particulates were visually observed in the tablets.

Terminated Particulate / foreign matter Watson Laboratories Inc NDC 0591-5513-05 D-397-2014
Class I · High risk

Lidocaine HCl Injection

Presence of Particulate Matter- Confimed customer complaint of particulates embedded in glass container and in contact with product solution.

Terminated Particulate / foreign matter Hospira Inc. NDC 0409-2066-05 D-1278-2014
Class II · Moderate risk

Propofol Injectible Emulsion

Presence of Particulate Matter: Glass defect located on the interior neck of the vial identified glass surface abrasions and visible embedded particulate matter which could result in the potential for small glass flakes or embedded metal particulate to become dislodged into the solution.

Terminated Particulate / foreign matter Hospira Inc. NDC 0409-4699-30 D-1033-2014
Class II · Moderate risk

Carisoprodol IV

Presence of Foreign Substance; heavy metals (chromium, titanium etc) and inactive components of the product were visually observed during routine stability testing.

Terminated Particulate / foreign matter Physicians Total Care, Inc. D-390-2014
Class I · High risk

Hyperlyte CR

Presence of Particulate Matter: B. Braun Medical Inc. is recalling several injectable products due to visible particulate matter found in reserve sample units.

Terminated Particulate / foreign matter B. Braun Medical Inc NDC 0264-1943-20 D-1275-2014
Class I · High risk

ProcalAmine

Presence of Particulate Matter: B. Braun Medical Inc. is recalling several injectable products due to visible particulate matter found in reserve sample units.

Terminated Particulate / foreign matter B. Braun Medical Inc NDC 0264-1915-07 D-1274-2014
Class I · High risk

TrophAmine

Presence of Particulate Matter: B. Braun Medical Inc. is recalling several injectable products due to visible particulate matter found in reserve sample units.

Terminated Particulate / foreign matter B. Braun Medical Inc NDC 0264-9341-55 D-1273-2014
Class I · High risk

15% Amino Acids Injection PBP Glass

Presence of Particulate Matter: B. Braun Medical Inc. is recalling several injectable products due to visible particulate matter found in reserve sample units.

Terminated Particulate / foreign matter B. Braun Medical Inc NDC 0264-3200-55 D-1272-2014
Class I · High risk

6.9% FreAmine HBC

Presence of Particulate Matter: B. Braun Medical Inc. is recalling several injectable products due to visible particulate matter found in reserve sample units.

Terminated Particulate / foreign matter B. Braun Medical Inc NDC 0264-9350-55 D-1271-2014
Class I · High risk

0.9 % Sodium Chloride Injection USP

Presence of Particulate Matter: B. Braun Medical Inc. is recalling several injectable products due to visible particulate matter found in reserve sample units.

Terminated Particulate / foreign matter B. Braun Medical Inc NDC 0264-4000-55 D-1270-2014
Class I · High risk

0.9% Sodium Chloride Injection

Presence of Particulate Matter: Baxter is issuing a voluntary recall for these IV solutions due to particulate matter found in the solution identified as polyester and cotton fibers, adhesive-like mixture, polyacetal particles, thermally degraded PVC, black polypropylene and human hair embedded in the plastic bag

Terminated Particulate / foreign matter Baxter Healthcare Corp. NDC 0338-0049-31 D-1163-2014
Class I · High risk

5% Dextrose Injection

Presence of Paticulate Matter; Baxter is issuing a voluntary recall for these IV solutions due to particulate matter found in the solution identified as polyester and cotton fibers, adhesive-like mixture, polyacetal particles, thermally degraded PVC, black polypropylene and human hair embedded in the plastic bag

Terminated Particulate / foreign matter Baxter Healthcare Corp. NDC 0338-0017-38 D-1162-2014
Class II · Moderate risk

Carisoprodol Tablets

Presence of Foreign Substance; heavy metals (chromium, titanium etc) and inactive components of the product were visually observed during routine stability testing

Terminated Particulate / foreign matter West-Ward Pharmaceutical Corp. NDC 0143-9749-10 D-367-2014
Class I · High risk

Soliris (eculizumab)

Presence of Particulate Matter: Failed the appearance test for the presence of visible particles.

Terminated Particulate / foreign matter Alexion Pharmaceuticals, Inc. NDC 25682-001-01 D-1049-2014

Recalls by year